Emmaus Life Sciences, Inc. Earnings Per Share Diluted

• Emmaus Life Sciences, Inc. showed a decrease of -20.0% in Earnings Per Share Diluted from 2024 to 2025.
• This data is from Emmaus Life Sciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
• XBRL data for this metric is available from 2011 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q4 2010: $0.00 per share | Q1 2011: $3.72 (loss) per share | Q4 2011: $0.05 (loss) per share | Q1 2012: $4.48 (loss) per share | Q2 2012: $0.51 per share | Q4 2012: $0.48 (loss) per share | Q1 2013: $0.07 (loss) per share | Q2 2013: $0.03 (loss) per share | Q4 2013: $0.00 per share | Q1 2014: $0.01 (loss) per share | Q4 2014: $0.01 (loss) per share | Q3 2018: $0.13 (loss) per share | Q3 2019: $0.60 (loss) per share | Q2 2021: $0.05 per share | Q3 2021: $0.06 (loss) per share | Q1 2022: $0.03 (loss) per share | Q2 2022: $0.18 (loss) per share | Q3 2022: $0.01 (loss) per share | Q1 2023: $0.07 (loss) per share | Q2 2023: $0.03 (loss) per share | Q3 2023: $0.01 (loss) per share | Q1 2024: $0.07 (loss) per share | Q2 2024: $0.03 (loss) per share | Q3 2024: $0.03 per share | Q1 2025: $0.04 (loss) per share | Q2 2025: $0.02 (loss) per share | Q3 2025: $0.03 (loss) per share.
• Over the full 8 years of available data (2011 to 2025), Emmaus Life Sciences, Inc.'s Earnings Per Share Diluted has grown by 97.5%.
• Historical annual values: Fiscal year 2025: $0.12 (loss) per share | Fiscal year 2024: $0.10 (loss) per share | Fiscal year 2023: $0.07 (loss) per share | Fiscal year 2022: $0.21 (loss) per share | Fiscal year 2021: $0.32 (loss) per share | Fiscal year 2013: $0.14 (loss) per share | Fiscal year 2012: $1.81 (loss) per share | Fiscal year 2011: $4.74 (loss) per share.
• Data sourced from SEC EDGAR public filings as of August 8, 2026.

Last verified: August 8, 2026